HPTN 035 (topical microbicides) effect on preventing STIs and HIV/AIDS, Microbicides Network Trials

Study description: HPTN 035 is Phase II/IIb, four-arm, multisite, randomized controlled trial comparing BufferGel and 0.5% PRO 2000/5 Gel (P) (topical microbicides for the prevention of HIV during sexual intercourse) with a placebo gel and with no gel. This study will recruit sexually active HIV-uninfected women from the following countries: Malawi, South Africa, Tanzania, Zambia, Zimbabwe, and the U.S. The primary objective of HPTN 035 is to determine the safety and effectiveness of two candidate vaginal microbicides: BufferGel and 0.5% PRO 2000 Gel (P). Study enrollment closed; results expected in 2009.

Bulletin of the World Health Organization (BLT) Volume 82, Number 6, June 2004

This Bulletin volume contains different papers related to syphilis.

Prevalence of reproductive tract infections, genital prolapse, and obesity in a rural community in Lebanon, Mary E. Deeb et al., Bulletin of the World Health Organization 2003, 81

The study objective is to determine the prevalence of reproduction-related illnesses in a rural community in Lebanon. Data were collected through interviews with women in their homes, physical examinations and history taking by physicians in a clinic in the community, and laboratory tests. A total of 557 ever-married women aged 15–60 years were selected randomly. The study shows a low prevalence rate of STIs.